The Lok Sabha 2024 elections mark an important moment in India's political landscape. The National Democratic Alliance (NDA), led by the Bharatiya Janata Party (BJP), secured 291 seats and formed the government. Despite falling short of a majority, the senior leaders of the BJP, under the stewardship of Prime Minister Narendra Modi, appear to exude an air of confidence.
Following the establishment of the new government, ministerial positions have been swiftly assigned. The Cabinet Committee on Security (CCS) retains its existing portfolios, without any alterations. Meanwhile, JP Nadda has been appointed as the new Union Minister for Health and Family Welfare.
How will these political events influence India and its economy? What repercussions could they have on the nation's healthcare sector? We sought perspectives from leading industry figures on these developments. From evaluating the present landscape to offering an analysis of potential challenges and opportunities, the industry leaders provide insights into how the future might unfold in the coming years, if not months.
OPTIMISTIC GROWTH TRAJECTORY EXPECTED
Arushi Jain, Director, Akums Drugs and Pharmaceuticals
The re-elected government is heralding a positive future for the pharma and health sector, emphasizing transformative advancements. High expectations are set for progress in research and fostering medical innovation. Increased research funding and streamlined regulations will hasten new treatments for rare diseases, boosting industry efficiency.
The commitment to 'Made in India' manufacturing aims to fortify the sector, promoting self-reliance and enhancing global standing. Infrastructure improvements promise to revolutionize healthcare delivery nationwide. Government incentives like the PLI scheme are expected to drive investment and growth.
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
KIMSHEALTH launches electrophysiology lab with 3D mapping
'ENSITE X' is the first of its kind in Kerala and the third in India enabling precise identification, mapping, and targeting the abnormal electrical activities in the heart.
Molbio boosts Goa's healthcare system with CSR initiatives
The company has donated four state-of-the-art Advanced Life Support (ALS) ambulances and two hearse vans for National Highway emergencies
USV introduces affordable heart failure medication
This cost-effective option addresses the rising cases of heart failure in India, offering lifesaving care to millions of patients who need it the most.
City Imaging & Clinical Labs to expand services to 50 hospitals
The company is currently associated with 10 hospitals, providing comprehensive lab management services, including 24/7 in-house phlebotomy and lab testing.
Oncare raises $1 million in seed funding, to set up 10 units
Oncare has raised $1 million in a seed funding round led by Huddle Ventures. It plans to deploy the raised capital to expand its operations to 10 new centers.
Nutrabay forays into Ayurvedic supplements market with Shilajit
Nutrabay's aims at gaining market share from the existing ayurveda supplements market with a distinctive product proposition and education about the benefits of Shilajit.
INDIA'S PREPAREDNESS ON HEALTHCARE-ASSOCIATED INFECTIONS: A GROWING FOCUS ON PATIENT SAFETY
The country's diverse healthcare landscape necessitates a flexible and multifaceted approach to infection control that can be adapted to various settings and resource levels.
TRANSFORMING CARDIAC SURGERY: HOW AI IS REVOLUTIONIZING PATIENT CARE AND OUTCOMES
Dr. Swarup Swaraj Pal shared his insights on the current state and future prospects of AI in cardiac procedures.
BEYOND THE LAB: THE CRITICAL ROLE OF LOGISTICS IN INDIA'S PHARMACEUTICAL INDUSTRY
As India continues to expand its role in the global pharmaceutical market, the importance of a robust, reliable, and innovative logistics infrastructure cannot be overstated.
LIFESTYLE DISEASES IN CHILDREN: A WAKE-UP CALL FOR A HEALTHIER GENERATION
In today's fast-paced world, children face an unexpected enemy: lifestyle diseases. Conditions like obesity, Type 2 diabetes, and hypertension are now affecting our youth. What's causing this shift, and how can we combat it?
